ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,29
0,48%
Dow Jones
39 671,04
0,00%
DAX
18 756,66
0,40%
Brent Oil
82,425
1,10%
Bitcoin
69 734,31
0,91%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Seres Therapeutics Inc (MCRB)

  7. Seres Therapeutics Inc (MCRB) Actualités

MCRB

Seres Therapeutics (MCRB)

Seres Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MCRB
DateHeureSourceTitreSymboleSociété
18/05/202402h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
08/05/202416h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MCRBSeres Therapeutics Inc
08/05/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
08/05/202413h00Business WireSeres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:MCRBSeres Therapeutics Inc
06/05/202422h01Business WireSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MCRBSeres Therapeutics Inc
06/05/202415h30Business WireSeres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024NASDAQ:MCRBSeres Therapeutics Inc
09/04/202413h00Business WireSeres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCTNASDAQ:MCRBSeres Therapeutics Inc
05/03/202416h18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MCRBSeres Therapeutics Inc
05/03/202416h13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MCRBSeres Therapeutics Inc
05/03/202413h00Business WireSeres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:MCRBSeres Therapeutics Inc
05/03/202412h05IH Market NewsU.S. Futures Dip, Crude Oil FluctuatesNASDAQ:MCRBSeres Therapeutics Inc
28/02/202413h00Business WireSeres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024NASDAQ:MCRBSeres Therapeutics Inc
27/02/202413h00Business WireSeres Therapeutics to Participate in Cowen 44th Annual Healthcare ConferenceNASDAQ:MCRBSeres Therapeutics Inc
26/02/202413h00Business WireSeres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David ArkowitzNASDAQ:MCRBSeres Therapeutics Inc
23/02/202422h05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MCRBSeres Therapeutics Inc
09/01/202414h10Dow Jones NewsSeres Therapeutics Shares Rise 15% After Getting FDA Fast-Track Designation for Infection TreatmentNASDAQ:MCRBSeres Therapeutics Inc
09/01/202413h00Business WireSeres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155NASDAQ:MCRBSeres Therapeutics Inc
04/01/202422h00Business WireSeres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:MCRBSeres Therapeutics Inc
08/12/202301h46Business WireSeres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023NASDAQ:MCRBSeres Therapeutics Inc
28/11/202315h18Business WireSeres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ETNASDAQ:MCRBSeres Therapeutics Inc
28/11/202301h01PR Newswire (US)Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science LeadersNASDAQ:MCRBSeres Therapeutics Inc
21/11/202312h00PR Newswire (US)Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of GeneticsNASDAQ:MCRBSeres Therapeutics Inc
02/11/202312h00Business WireSeres Therapeutics Reports Third Quarter 2023 Financial Results Including VOWST™ Net Sales of $7.6 MillionNASDAQ:MCRBSeres Therapeutics Inc
01/11/202315h30PR Newswire (US)Flagship Pioneering Launches Pioneering IntelligenceNASDAQ:MCRBSeres Therapeutics Inc
30/10/202322h30Business WireSeres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. ESTNASDAQ:MCRBSeres Therapeutics Inc
12/10/202313h00Business Wire Seres Therapeutics to Highlight VOWST™ Data at IDWeekNASDAQ:MCRBSeres Therapeutics Inc
11/09/202312h30PR Newswire (US)Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development OfficerNASDAQ:MCRBSeres Therapeutics Inc
07/09/202316h00Business WireSeres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:MCRBSeres Therapeutics Inc
29/08/202315h00PR Newswire (US)Invaio achieves first registration for citrus greening solution featuring Trecise™ technologyNASDAQ:MCRBSeres Therapeutics Inc
16/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MCRBSeres Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MCRB

Dernières Valeurs Consultées

BIT
P1XQU7
NLBNPIT1XQU7 20991231 23...
EU
Q426S
Q426S
LSE
DDDD
4d Pharma
BIT
NSCIT0554740
Italy
USOTC
CJEWY
Chow Tai Fook Jewellery (PK)
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés